New drug fights dangerous virus in transplant patients
Disease control
Completed
This study tested a new drug called AntiBKV to see if it could safely reduce BK virus levels in the blood of kidney transplant recipients. The virus can damage the new kidney. 95 participants received either the drug or a placebo through four IV infusions over several months. Res…
Phase: PHASE2, PHASE3 • Sponsor: Memo Therapeutics AG • Aim: Disease control
Last updated Apr 02, 2026 10:57 UTC